Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of medicine for preventing and treating diabetes and diabetic nephropathy and its synthesis method and application

A technology of diabetic nephropathy and synthetic method, which is applied in the field of related drugs, can solve problems such as unsatisfactory activity and structure-activity relationship research, and achieve the effect of optimizing the synthetic route, easily obtaining synthetic raw materials, and easy separation and purification

Active Publication Date: 2019-02-22
XIAN UNIV OF SCI & TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] With the deepening of research, the original method of extracting compounds from natural products can no longer meet the needs of activity and structure-activity relationship research. It is necessary to study new synthetic methods. At the same time, more in-depth research on caffeic acid-phenylalanine It is also very meaningful to study the biological activity of acid amide compounds and their analogs, and to provide them with new applications, especially in pharmaceutical applications.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of medicine for preventing and treating diabetes and diabetic nephropathy and its synthesis method and application
  • A kind of medicine for preventing and treating diabetes and diabetic nephropathy and its synthesis method and application
  • A kind of medicine for preventing and treating diabetes and diabetic nephropathy and its synthesis method and application

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0047] The synthesis of example 1 caffeic acid-phenylalanine amide compound (CP1 for short, as shown in formula II)

[0048]

[0049] 1) Weigh 90mg (0.5mmol) of caffeic acid and add it to a 10mL round-bottomed flask, add 5mL of trichloroethane dropwise to the round-bottomed flask to dissolve the caffeic acid;

[0050] 2) Add 208 μL (about 1.5 mmol) of triethylamine to the round bottom flask, and stir for 10 min in an ice-water bath to bring the temperature of the system to 0°C;

[0051] 3) Add 143 mg (0.75 mmol) of EDCI (1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride) and DMAP ( 4-Dimethylaminopyridine) 91.5mg (0.75mmol), after 20min, add L-phenylalanine hydrochloride 101mg (0.5mmol) to the round-bottomed flask, the temperature rose to 40°C, and continued stirring Respond for 24 hours;

[0052] 4) After the reaction was completed, the solvent was vacuum-dried (rotary evaporation, -0.08MPa, 45°C), and 20 mL of ethyl acetate was added to shake well, and filtered...

example 2

[0053] The synthesis of example 2 ferulic acid-phenylalanine isopropyl ester (CP2 for short, as shown in formula III)

[0054]

[0055] 1) Weigh 97 mg (0.5 mmol) of ferulic acid and add it to a 10 mL round-bottomed flask, add 6 mL of DCM (dichloromethane) dropwise to the round-bottomed flask to dissolve the ferulic acid;

[0056] 2) Add 205 μL (about 1.5 mmol) of diisopropylamine to the round bottom flask, and stir for 15 minutes in an ice-water bath to make the temperature of the system reach 0°C;

[0057] 3) Add NMM (N-methylmorpholine) 101mg (1mmol) and IBCF (isobutyl chloroformate) 135mg (1mmol) to the round-bottomed flask under ice-water bath and stirring conditions, and pour into the round-bottomed flask after 40min Then add 101 mg (1 mmol) of L-phenylalanine isopropyl ester hydrochloride, raise the temperature to 80°C, and continue to react under stirring conditions for 18 hours;

[0058] 4) After the reaction was completed, the solvent was vacuum-dried (rotary evap...

example 3

[0059] Example 3 Synthesis of 3-acetyl-caffeic acid-β-naphthylalanine benzyl ester (CP3 for short, shown in formula IV)

[0060]

[0061] 1) Weigh 111mg (0.5mmol) of the raw material 3-acetyl-caffeic acid (structural formula is as follows) into a 10mL round-bottomed flask, and add 5mL of toluene dropwise into the round-bottomed flask to dissolve the raw material;

[0062]

[0063] 2) Add 70 μL (about 0.5 mmol) of triethylamine to the round-bottomed flask, and stir for 20 minutes in an ice-water bath to make the temperature of the system reach 0°C;

[0064] 3) Add EDCI 95mg (0.5mmol) and HOBt67.3mg (0.5mmol) to the round bottom flask under ice-water bath and stirring conditions, and then add β-L-naphthylalanine benzyl ester to the round bottom flask after 30min 183mg (0.6mmol), the temperature was raised to 60°C, and the reaction was continued for 48 hours under stirring;

[0065] 4) After the reaction was completed, the solvent was vacuum-dried (rotary evaporation, -0.0...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for preventing and treating diabetes and diabetic nephropathy, and a synthetic method and an application thereof. The medicine is a caffeic acid-phenylalanine derivative, and has a structure represented by formula I; and in the formula I, R<1> and R<2> are H, OH, OCH3, OCOCH3, 3-methylbutyl-2-vinyl group or an isopentenyl group, R<3> is H, CH3, Bn, OCH3, OCOCH3, BnCH2, i-Pr, t-Bu or an adamantyl group, and n is 0 or 1. An STZ induced rat diabetic model shows that the derivative substantially reduces the blood sugar of diabetic model rats, and has a certain protection effect on diabetic nephropathy model mice, so the blood sugar reducing effect and the kidney protecting effect of the derivative are confirmed, and the derivative can be used to prepare diabetes and diabetic nephropathy correlated medicines.

Description

technical field [0001] The invention belongs to the field of pharmacy, and relates to the application of caffeic acid-phenylalanine derivatives in hypoglycemic and renal protection, and in particular to the application of the derivatives in the preparation of anti-diabetes and its complications and other related drugs. Background technique [0002] Caffeic acid-phenylalanine amide compound (Caffeoyl-N-phenylalanine), the chemical name is (trans)-3-(3,4-dihydroxyphenyl)acrylic acid-L-phenylalanine, widely exists in various In coffee beans, such as Coffea arabica, Coffea argentina, Robusta coffee, etc., this compound was isolated and identified for the first time in 1955 by Klaus Peter Adam's research group from Athyrium filix-femina. Subsequent studies have found that the compound is also widely present in other plants. [0003] Similar to the caffeic acid phenethyl compound in propolis, the caffeic acid-phenylalanine amide compound also has a very wide range of biological a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C231/02C07C235/34A61K31/198A61K31/216A61P3/10A61P13/12
CPCC07C231/02C07C235/34
Inventor 陈福欣龚频侯彬彬王兰文和马逢乐周安宁
Owner XIAN UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com